Endonovo Therapeutics Inc (ENDV) Return on Assets ROA from the third quarter of 2023 to third quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Endonovo Therapeutics Inc   (ENDV)


Endonovo Therapeutics Inc 's ROA from the third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Endonovo Therapeutics Inc 's ROA in the third quarter of 2023?
Endonovo Therapeutics Inc recorded a cumulative net loss of $-4 million during 12 months ending in the third quarter of 2023, resulting in a negative return on assets (ROA) of -408.66%.

However, within the Healthcare sector 1066 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2023 quarter, so far to 5298, from total ROA ranking in the second quarter of 2023 at 5398.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Total Assets Change -43.79 % -36.37 % -33.95 % -36.17 % -32.08 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -4 -4 -9 -18 -3
Return On Assets (TTM) -408.66 % -342.99 % -639.2 % -1203.08 % -183.24 %
ENDV's Total Ranking # 5298 # 5398 # 5601 # 6459 # 5476
Total Assets (TTM) in million 1 1 1 1 1
Seq. Total Assets Change -19.62 % -15.35 % -6.43 % -11.71 % -9.01 %
Seq. Net Income Change - -71.46 % - - -

ENDV's 5 Years Annual ROA >> Back to ENDV Management Effectiveness >> Compare ENDV ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 235
Sector # 1067
Overall # 5194

Return On Assets Statistics
High Average Low
9975.83 %
-529.55 %
-7932.66 %
(Mar 31 2015)   (Dec 31 2015)





Financial Statements
Endonovo Therapeutics Inc 's Assets $ 1 million ENDV's Balance sheet
Endonovo Therapeutics Inc 's Income $ -1 million Quarterly ENDV's Income Statement
ENDV's Income by Division See ENDV's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018
Y / Y Total Assets Change -36.17 % -25.53 % -17.7 % -22.81 % -8.02 %
Total Assets in million 1 2 3 3 4
Y / Y Net Income Change - - - - -
Net Income in million -18 -3 0 -17 -6
Annual Return On Assets -1441.9 % -154.69 % -14.68 % -528.74 % -151.71 %

ENDV's 5 Years Annual ROA >> Back to ENDV Management Effectiveness >> Compare ENDV ROA to its Competitors



More Return On Assets Ratios
ENDV's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ENDV's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ENDV's Competitors
Subscribers only: Roa for Endonovo Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for ENDV's Customers

You may also want to know
ENDV's Roi ENDV's Inventory Turnover Ratio ENDV's Growth Rates ENDV's Dividend Comparisons
ENDV's Profitability Ratios ENDV's Asset Turnover Ratio ENDV's Dividend Growth
ENDV's Roe ENDV's Valuation Ratios ENDV's Financial Strength Ratios ENDV's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2023, within Healthcare Sector ROA

Date modified: 2026-09-08T15:11:08+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.